Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ROSE study: entrectinib in ROS1-fusion-positive pediatric brain tumors
jRCTs041200030Completed
- Start
- Aug 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of entrectinib in brain neoplasm. Primary endpoint: Overall best response until four courses. Started Aug 2020; status: completed.
02
Drugs
entrectinib
03
Conditions
brain neoplasm
Beyond the preview
Go deeper on jRCTs041200030.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs041200030.